Laurie M. Strawn

SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

Alexander Laird, Peter Vajkoczy, Laura K. Shawver et al. · PubMed · 2000 · 497 citations

Pathology, Cancer Biology, Tumor Biology +23

Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.

B Millauer, M P Longhi, Karl H. Plate et al. · PubMed · 1996 · 424 citations

Pathology, Cancer Biology, Glioma +18

Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor.

Laurie M. Strawn, E Mann, Susan S. Elliger et al. · Journal of Biological Chemistry · 1994 · 116 citations · Full text

Receptor tyrosine kinases as targets for inhibition of angiogenesis

Laura K. Shawver, Kenneth E. Lipson, T. Annie T. Fong et al. · Drug Discovery Today · 1997 · 78 citations

Angiogenesis, Medicine, Receptor Tyrosine Kinase +7

Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials

Laurie M. Strawn, Laura K. Shawver · Expert Opinion on Investigational Drugs · 1998 · 75 citations

Kinase Inhibitors, Pathology, Pharmacotherapy +17